![Fabian Zohren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fabian Zohren
Directeur Technique/Scientifique/R&D chez
MERUS N.V.
Profil
Fabian Zohren currently works at Merus NV, as Chief Medical Officer from 2024.
Dr. Zohren also formerly worked at ImmunoGen, Inc., as Chief Medical Officer & Senior Vice President from 2023 to 2024.
Dr. Zohren received his doctorate degree from Heinrich-Heine-Universität Düsseldorf.
Postes actifs de Fabian Zohren
| Sociétés | Poste | Début |
|---|---|---|
| MERUS N.V. | Directeur Technique/Scientifique/R&D | 01/07/2024 |
Anciens postes connus de Fabian Zohren
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOGEN, INC. | Directeur Technique/Scientifique/R&D | 31/05/2024 |
Formation de Fabian Zohren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Heinrich-Heine-Universität Düsseldorf
 Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
